Literature DB >> 9062585

Bloom's syndrome. XX. The first 100 cancers.

J German1.   

Abstract

As of 1996 the 100th cancer was diagnosed in Bloom's syndrome. The cancers have been regularly documented since 1960 in a program of surveillance referred to as the Bloom's Syndrome Registry. Tabulated here are their types and ages of onset. The 100 cancers arose in 71 of the 168 registered individuals. Represented in Bloom's syndrome are both the cancers that commonly affect the general population and the rare tumors of early childhood. This body of information has become sufficiently large to be useful to geneticists and physicians in advising affected families concerning cancer risk. Of more general significance, however, the distribution of cancer sites and types sets Bloom's syndrome apart from other cancer-predisposing genetically determined conditions, affirming its experimental value as a model for analyzing the nonenvironmental component in the etiology of the generality of human cancer.

Entities:  

Mesh:

Year:  1997        PMID: 9062585     DOI: 10.1016/s0165-4608(96)00336-6

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  89 in total

Review 1.  Immunodeficiency associated with DNA repair defects.

Authors:  A R Gennery; A J Cant; P A Jeggo
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

Review 2.  Replication proteins and human disease.

Authors:  Andrew P Jackson; Ronald A Laskey; Nicholas Coleman
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-01-01       Impact factor: 10.005

3.  Regulation of gene expression by the BLM helicase correlates with the presence of G-quadruplex DNA motifs.

Authors:  Giang Huong Nguyen; Weiliang Tang; Ana I Robles; Richard P Beyer; Lucas T Gray; Judith A Welsh; Aaron J Schetter; Kensuke Kumamoto; Xin Wei Wang; Ian D Hickson; Nancy Maizels; Raymond J Monnat; Curtis C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

Review 4.  The Emerging Role of Cytidine Deaminase in Human Diseases: A New Opportunity for Therapy?

Authors:  Audrey Frances; Pierre Cordelier
Journal:  Mol Ther       Date:  2019-12-06       Impact factor: 11.454

Review 5.  Osteosarcoma: Molecular Pathogenesis and iPSC Modeling.

Authors:  Yu-Hsuan Lin; Brittany E Jewell; Julian Gingold; Linchao Lu; Ruiying Zhao; Lisa L Wang; Dung-Fang Lee
Journal:  Trends Mol Med       Date:  2017-07-20       Impact factor: 11.951

6.  BLM's balancing act and the involvement of FANCJ in DNA repair.

Authors:  Srijita Dhar; Robert M Brosh
Journal:  Cell Cycle       Date:  2018-09-23       Impact factor: 4.534

7.  Control of translocations between highly diverged genes by Sgs1, the Saccharomyces cerevisiae homolog of the Bloom's syndrome protein.

Authors:  Kristina H Schmidt; Joann Wu; Richard D Kolodner
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

8.  Bloom syndrome: multiple retinopathies in a chromosome breakage disorder.

Authors:  R B Bhisitkul; M Rizen
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

9.  Global transcriptional response to carbonic anhydrase IX deficiency in the mouse stomach.

Authors:  Heini Kallio; Mika Hilvo; Alejandra Rodriguez; Eeva-Helena Lappalainen; Anna-Maria Lappalainen; Seppo Parkkila
Journal:  BMC Genomics       Date:  2010-06-23       Impact factor: 3.969

Review 10.  Current status and perspectives regarding the treatment of osteo-sarcoma: chemotherapy.

Authors:  Akio Sakamoto; Yukihide Iwamoto
Journal:  Rev Recent Clin Trials       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.